BIO Protocol has raised $30.2 million through fundraising. The private placement was conducted in two rounds, with a total financing of $2.3 million and valuations of $35 million and $69 million respectively. The public placement was conducted in three rounds (BIO Genesis auction), with a total financing of $27.9 million and valuations of $85 million, $142 million, and $219 million respectively. Currently, BIO has been listed on Bybit and Bitget for pre-market trading, and based on the pre-market average price of $0.9659 on both platforms at 22:00 on December 29th, the FDV of BIO is approximately $3.2 billion. Private placement investors account for 13.60% of the total supply, while public placement investors account for 20.00% of the total supply. The costs are as follows:

Private placement:

· Pre-seed round: cost about $0.01054, currently floating profit of 91.62 times;

· Seed round: cost about $0.02078, currently floating profit of 46.48 times;

Public placement:

· Round 1: cost about $0.0256, currently floating profit of 37.73 times;

· Round 2: cost about $0.04277, currently floating profit of 22.58 times;

· Round 3: cost about $0.06596, currently floating profit of 14.64 times.